Europe follows FDA with plans to help early Alzheimer's drugs

LONDON (Reuters) – European regulators are following in the footsteps of the U.S. Food and Drug Administration with plans to help pharmaceutical companies win approval for novel Alzheimer’s drugs that treat the earliest stages of the memory-robbing disease.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *